| mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.8 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.9 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.0081 |
0.9 |